101 results
Page 3 of 6
POS AM
pf5hp0xv
27 Aug 21
Prospectus update (post-effective amendment)
12:00am
6-K
EX-99.2
acd75cv
16 Aug 21
Interim Consolidated Financial Statements
12:00am
424B3
pkfbb1mahtw30b0
9 Aug 21
Prospectus supplement
12:00am
F-6 POS
EX-1
1ktkw4ggeoeoq
26 Jul 21
Automatic registration for ADRs (post-effective amendment, foreign)
10:38am
F-1/A
xu5bm945egwyo1nsyas
28 Apr 21
Registration statement (foreign) (amended)
4:38pm
F-1
43skp1ujgfy kx9
21 Apr 21
Registration statement (foreign)
4:17pm
6-K
EX-99.2
177v5xp
2 Mar 21
Report of Foreign Private Issuer
4:05pm
424B3
rl95h4jqe 1l3a706t9
3 Feb 21
Prospectus supplement
12:10pm
6-K
EX-1.1
w5mzl
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
424B4
pbg shvnwyx
20 Nov 20
Prospectus supplement with pricing info
4:43pm
FWP
lfvjed00uczmm tt
5 Nov 20
Free writing prospectus
5:11pm
F-1/A
EX-4.6
e9tv1y50gk4zqj2e2m
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
EX-1.1
74njmsdkmgyu1xxsla7
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
f7vj5 u1niv
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
FWP
dlu 87bhklxb
21 Oct 20
Free writing prospectus
7:26am
F-1/A
m5oww
20 Oct 20
Registration statement (foreign) (amended)
9:57pm
424B3
8i7h795x6s5s
13 Oct 20
Prospectus supplement
9:42am